By Kathleen Blanchard RN for eMaxHealth.com
A new drug is being developed that is a breakthrough for treating type 2 diabetes. Research led by scientists at the Karolinska Institutet have found a way to block signaling by a protein known as VEGF-B, which in turn helps cells in the body respond to insulin. The drug is already in development by the biopharmaceutical company CSL Limited.
The finding is considered a breakthrough for type 2 diabetes because it’s an entirely new approach to treating the disease.
To learn more, head here.